Paper Details
- Home
- Paper Details
Formulation, development, and <i>in-vitro</i>/<i>ex-vivo</i> evaluation of vaginal bioadhesive salbutamol sulfate tablets for preterm labor.
Author: El-EninAmal S M Abu, ElbakryAsmaa M, HosaryRania El, LotfyMarwa Ahmed Fouad
Original Abstract of the Article :
Preterm labor is the main cause of death and serious illness of both infants and pregnant women in Africa and worldwide. Parenteral and oral salbutamol sulfate as a B<sub>2</sub> antagonist has been used for the treatment of preterm labor. The study aims are to formulate salbutamol sulfate non-invas...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1080/10837450.2020.1767129
データ提供：米国国立医学図書館（NLM）
Vaginal Bioadhesive Salbutamol Sulfate Tablets for Preterm Labor
The desert of preterm labor is a perilous landscape, fraught with challenges for both mother and child. This study explores the potential of a novel drug delivery system, vaginal bioadhesive salbutamol sulfate tablets, for the treatment of preterm labor. The researchers aimed to develop a non-invasive, localized delivery system that avoids the side effects associated with conventional oral and parenteral formulations. The study successfully formulated vaginal bioadhesive tablets with promising in-vitro and ex-vivo results, suggesting potential for a safer and more effective treatment option for preterm labor.
Vaginal Bioadhesive Salbutamol Sulfate Tablets: A Potential Breakthrough in Preterm Labor Treatment
The study successfully formulated vaginal bioadhesive salbutamol sulfate tablets, demonstrating promising in-vitro and ex-vivo results. The researchers highlighted the potential for this non-invasive, localized drug delivery system to provide a safer and more effective treatment option for preterm labor, potentially reducing the need for traditional oral and parenteral formulations and their associated side effects.
A New Approach to Treating Preterm Labor: Targeted Drug Delivery
This study explores a novel approach to treating preterm labor, using vaginal bioadhesive salbutamol sulfate tablets to deliver the medication directly to the site of action. This targeted delivery strategy aims to enhance efficacy and minimize systemic side effects, potentially offering a safer and more effective treatment option for preterm labor. The study's findings pave the way for further research and clinical trials to evaluate the safety and efficacy of this promising new approach.
Dr. Camel's Conclusion
This study highlights the potential of vaginal bioadhesive salbutamol sulfate tablets as a promising new treatment option for preterm labor. The researchers have successfully formulated tablets with promising in-vitro and ex-vivo results, suggesting a safer and more effective alternative to conventional drug delivery methods. As a wise camel, I am hopeful that this research will lead to the development of innovative and effective treatments for this challenging condition.
Date :
- Date Completed 2021-06-17
- Date Revised 2021-06-17
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.